Martin Voss
MD
Attending Physician, GU Oncology
👥Biography 个人简介
Martin Voss is a leading investigator in HIF-2alpha targeted therapy and VHL-associated kidney cancer. He has been a key researcher in belzutifan clinical trials for both hereditary and sporadic RCC. His translational work on HIF pathway biology and resistance mechanisms is advancing next-generation therapeutic strategies for kidney cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Martin Voss 的研究动态
Follow Martin Voss's research updates
留下邮箱，当我们发布与 Martin Voss（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment